Delivery Order SPE2DB20D2014-SPE2DB25FD19T
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, represents pharmaceutical procurement under the company's larger contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $3,073.44 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $8,408.40 with a completion date of September 30, 2025. This non-competitive delivery order represents a firm fixed price transaction executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply agreement running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 ml pens valued at $5,236.50 on July 29, 2025, with completion scheduled for July 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $3,603.60 delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on September 4, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price contract represents a non-set-aside competitive award, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,501.50 for Trulicity 3 mg/0.5 mL pens on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $3,929.28 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on September 22, 2025, with completion expected by September 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a direct procurement of the diabetes medication to support federal healthcare operations. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $11,940.80 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pens on September 23, 2025, with completion scheduled for September 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes management medication, consistent with...
- The Defense Logistics Agency awarded a $12,012 delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on September 24, 2025, with completion scheduled for September 25, 2025. This firm fixed price, non-set-aside contract represents a supply of the diabetes medication to support federal healthcare operations. The order will be fulfilled from AmerisourceBergen's facilities in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,051.05 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on August 11, 2025, with an ultimate completion date of August 12, 2025. This delivery order represents a firm fixed price, competitively awarded contract with no set-aside designation. The award was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and falls under the company's larger Indefinite Delivery Contract...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD19TDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,221.27 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on September 29, 2025, with completion expected by September 30, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded contract for pharmaceutical supply to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and operates as a major pharmaceutical distributor for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion comprehensive global pharmaceutical support vehicle extending through December 2026. The IDC serves as the primary vehicle enabling AmerisourceBergen to supply pharmaceuticals and medical supplies supporting military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. Trulicity, a diabetes management medication, exemplifies the specialty pharmaceutical products AmerisourceBergen delivers through its DLA contracts, which encompass brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 9/29/25 |